Stay updated on Fully-Human Anti-BCMA CAR T Cells for Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Fully-Human Anti-BCMA CAR T Cells for Multiple Myeloma Clinical Trial page.

Latest updates to the Fully-Human Anti-BCMA CAR T Cells for Multiple Myeloma Clinical Trial page
- Check5 days agoChange DetectedA new version entry was added to the record history, documenting recent updates to the page; substantive study information appears unchanged.SummaryDifference0.0%

- Check12 days agoChange DetectedNew history entries were added for the record, showing updates to Study Status and Document Section across multiple dates. The updated version history extends the timeline from 2018 to 2026, reflecting ongoing changes to the trial record.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision history updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.0%

- Check26 days agoChange DetectedRevision: v3.4.3 was added to the page history, and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check33 days agoChange DetectedDifference0.1%

- Check55 days agoChange DetectedAdded revision v3.4.2 to the record history and removed the old government-funding notice and revision v3.4.1.SummaryDifference0.2%

Stay in the know with updates to Fully-Human Anti-BCMA CAR T Cells for Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fully-Human Anti-BCMA CAR T Cells for Multiple Myeloma Clinical Trial page.